Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 6Neoplasms 3Lung Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleural Effusion 1Pituitary Diseases 1Pituitary ACTH Hypersecretion 1Obesity 1Myasthenia Gravis 1Motor Activity 1Lymphoma 1Kidney Neoplasms 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Thoracoscopy 4vandetanib 1dalotuzumab 1X-Rays 1Ultrasonography 1Tyrosine Kinase Inhibitors 1Tissue Plasminogen Activator 1Thoracentesis 1Tenecteplase 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Povidone-Iodine 1Naproxen 1Hyperthermic Intraperitoneal Chemotherapy 1Fentanyl 1Diclofenac 1Deoxyribonucleases 1Dasatinib 1Clinical Laboratory Techniques 1Cisplatin 1Chest Tubes 1Biomarkers 1Afatinib 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pleural Effusion × Biomarkers × Clear all
NCT07012759 2026-03-05

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Fu Jen Catholic University

Recruiting
100 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡